Castle Biosciences to Present at Upcoming Investor Conferences
08 Noviembre 2023 - 12:00PM
Business Wire
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving
health through innovative tests that guide patient care, today
announced that the Company’s executive management is scheduled to
present a company overview at the following investor conferences
later this month:
- Stephens Annual Investment Conference on Nov. 15, 2023, at
11:00 a.m. Eastern Time.
- Canaccord Genuity MedTech, Diagnostics and Digital Health &
Services Forum on Nov. 16, 2023, at 9:00 a.m. Eastern time.
- Piper Sandler 35th Annual Healthcare Conference on Nov. 28,
2023, at 12:30 p.m. Eastern time.
Live audio webcasts of the Company’s presentations will be
available by visiting Castle Biosciences’ website at
https://ir.castlebiosciences.com/events-presentations/default.aspx.
Replays of the webcasts will be available following the conclusion
of the broadcasts.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics
company improving health through innovative tests that guide
patient care. The Company aims to transform disease management by
keeping people first: patients, clinicians, employees and
investors.
Castle’s current portfolio consists of tests for skin cancers,
uveal melanoma, Barrett’s esophagus and mental health conditions.
Additionally, the Company has active research and development
programs for tests in other diseases with high clinical need,
including its test in development to help guide systemic therapy
selection for patients with moderate-to-severe atopic dermatitis,
psoriasis and related conditions. To learn more, please visit
www.CastleBiosciences.com and connect with us on LinkedIn,
Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath
Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq,
TissueCypher and IDgenetix are trademarks of Castle Biosciences,
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231108949553/en/
Investor Contact: Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact: Allison Marshall
amarshall@castlebiosciences.com
Castle Biosciences (NASDAQ:CSTL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Castle Biosciences (NASDAQ:CSTL)
Gráfica de Acción Histórica
De May 2023 a May 2024